Back to today’s briefing

Story perspectives

Study Links GLP-1 Drugs to Increased GERD Risk

7/16/2025

23 2

Summary

Story summary

A recent study in the Annals of Internal Medicine reveals a concerning link for type 2 diabetes patients using GLP-1 drugs like Ozempic, showing a 27% higher risk of developing gastroesophageal reflux disease (GERD) compared to those taking SGLT-2 inhibitors. Oral health experts also caution about side effects such as dry mouth and heightened acid reflux associated with these treatments.

1 of 1

Story summary

A recent study in the Annals of Internal Medicine reveals a concerning link for type 2 diabetes patients using GLP-1 drugs like Ozempic, showing a 27% higher risk of developing gastroesophageal reflux disease (GERD) compared to those taking SGLT-2 inhibitors. Oral health experts also caution about side effects such as dry mouth and heightened acid reflux associated with these treatments.